Matthew Porteus

Matthew Porteus

Corporate Officer/Principal bei
Stanford School of Medicine
61 Jahre
Consumer Services
Health Technology

Profil

Matthew Porteus is the founder of CRISPR Therapeutics AG, founded in 2013.
Dr. Porteus was the founder of Graphite Bio, Inc., founded in 2017, and served as Director.
Dr. Porteus is also the founder of Kamau Therapeutics, Inc...
Dr. Porteus is a Professor at Stanford University.
Dr. Porteus is an Associate Professor at Stanford School of Medicine since 2010.
Dr. Porteus was an Assistant Professor at The University of Texas Southwestern Medical Center from 2003 to 2010.
Dr. Porteus completed undergraduate studies at Harvard University.
Dr. Porteus earned a doctorate from Stanford University.

Aktive Positionen von Matthew Porteus

UnternehmenPositionBeginn
Corporate Officer/Principal 01.10.2010
Corporate Officer/Principal -

Ehemalige bekannte Positionen von Matthew Porteus

UnternehmenPositionEnde
Corporate Officer/Principal 01.08.2010
LENZ THERAPEUTICS, INC. Gründer -
CRISPR THERAPEUTICS AG Gründer -
Sehen Sie sich die Erfahrung von Matthew Porteus im Detail an

Ausbildung von Matthew Porteus

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

95

Beziehungen ersten Grades

6

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen6

Consumer Services

Consumer Services

Consumer Services

Health Technology

Consumer Services

Health Technology

  1. Börse
  2. Insiders
  3. Matthew Porteus